Suppr超能文献

甜蜜素的代谢及其向环己胺的转化。

Metabolism of cyclamate and its conversion to cyclohexylamine.

作者信息

Collings A J

出版信息

Diabetes Care. 1989 Jan;12(1):50-5; discussion 81-2. doi: 10.2337/diacare.12.1.50.

Abstract

Since cyclamates were first introduced in the early 1950s, arguments have raged over the potential carcinogenicity of this artificial sweetener. Concern over the safety of cyclamates arises from observations that some individuals and experimental animals can metabolize cyclamate to cyclohexylamine and that cyclohexylamine has been shown to produce testicular atrophy in experimental animals. This study examines the absorption, excretion, and metabolism of cyclamate, particularly its conversion to cyclohexylamine. In addition, the potential toxicity and pharmacology of cyclohexylamine are discussed.

摘要

自20世纪50年代初甜蜜素首次被引入以来,关于这种人工甜味剂的潜在致癌性的争论就一直激烈进行着。对甜蜜素安全性的担忧源于一些观察结果,即一些个体和实验动物能够将甜蜜素代谢为环己胺,并且已证明环己胺会在实验动物中导致睾丸萎缩。本研究考察了甜蜜素的吸收、排泄和代谢情况,特别是其向环己胺的转化。此外,还讨论了环己胺的潜在毒性和药理学特性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验